A new gene called DEAR1 has been found to be genetically altered in breast tumors and may provide a new prognostic marker for breast cancer patients, particularly those with early-onset cancer. The research suggests that DEAR1-negative staining could help identify young women at high risk of cancer recurrence.
A study of breast cancer risk factors in young women suggests that risk assessment and prevention should start much earlier in life. The study found a link between breast tissue composition in young women and the risk of breast cancer in middle age and older.
A mother-daughter study found that breast water percentage in younger women is linked to increased breast cancer risk in middle age and older. The research suggests using magnetic resonance imaging (MRI) for early detection could aid in prevention methods.
A new imaging technique called breast elastography enables accurate diagnoses of breast cancer by analyzing tissue stiffness. This study found that breast elastography outperformed conventional ultrasound in diagnosing breast cancers, reducing unnecessary biopsies and patient anxiety.
A new computer algorithm assesses mammographic breast density by automatically segmenting breast tissue from background, removing muscle, and using region growing to determine dense areas. This method provides objective and accurate recommendations on further imaging or monitoring, reducing variability among radiologists.
Researchers at Georgetown University Medical Center found that hormone levels in blood do not accurately reflect breast cancer risk. The study suggests that measuring hormones in blood may give a false impression of breast cancer risk and an imprecise picture of how these hormones affect breast cancer development.
Researchers found that Muc4 promotes release of breast cancer cells from primary tumor, allowing them to survive and resist treatment. The study suggests that targeting Muc4 could lead to new treatments for breast and potentially other cancers.
A recent study found that early detection of second breast cancers in women who have already had the disease can significantly improve their chances of survival. The research revealed that mammography was more sensitive than clinical examination for detecting second cancers, with a sensitivity of 86%. Early detection at an asymptomatic...
Systematic literature reviews and meta-analyses support the use of risk assessment models combined with breast density information to identify high-risk postmenopausal women. Lifestyle factors such as exercise, weight reduction, and reduced alcohol intake also show promise in reducing breast cancer risk.
A new study published in Cancer Epidemiology, Biomarkers and Prevention found that red wine had no effect on breast cancer risk. Women who consumed moderate amounts of alcohol had a higher risk of breast cancer, regardless of the type of drink.
The new guidelines recommend using breast MRI to supplement standard imaging tools like mammography and ultrasound, particularly for detecting cancer in the contralateral breast. The guidelines also highlight the importance of clear standards for technical parameters and performance measures for clinical sites offering MRI services.
Researchers found that breast cancer cells can be made to express a transporter, allowing pyruvate to enter and induce cell death. The study aims to develop a new therapeutic target for fighting breast cancer.
A new study published in Cancer found that pregnancy does not affect breast cancer severity or survival rates, but can delay diagnosis and treatment. Women who develop breast cancer while pregnant or shortly after have similar outcomes to those without a history of pregnancy.
Researchers developed a 50-gene set to identify the four known types of breast cancer, allowing for personalized treatment. The test was found to be highly sensitive and predictive for chemotherapy response, particularly for poor-prognosis tumor types.
The ELLA Binational Breast Cancer Study reveals significant differences in breast cancer risk factors between Hispanic and non-Hispanic women. Hispanic women are at a higher risk of triple-negative breast cancer due to family history, while those born in Mexico exhibit increased risk due to geography and environment.
A new study has identified certain patient and tumor characteristics that may indicate which breast cancer patients are at high risk of developing contralateral breast cancer. These include histologic invasive characteristics, multiple quadrants affected, and a high Gail risk score or age over 50 at diagnosis.
Research at Albert Einstein College of Medicine found that high insulin levels in postmenopausal women are associated with a higher risk of developing breast cancer. Women with the highest insulin levels were nearly 50% more likely to develop breast cancer compared to those with lower insulin levels.
Researchers at Mayo Clinic found a strong association between dense breasts and increased breast cancer risk, citing tissue composition differences between dense and non-dense tissue. Dense breast tissue contains more epithelium and stroma, and higher aromatase enzyme levels than non-dense tissue.
Mayo Clinic researchers found that young women with atypical hyperplasia had a relative risk of developing breast cancer almost six times greater than those without BBD. A strong family history of breast cancer slightly increased the risk in two other forms of benign breast disease, but only marginally.
A study found that estrogen therapy can stop the growth of tumors or cause them to shrink in about a third of women with metastatic breast cancer that has developed resistance to standard estrogen-lowering therapy. The high-dose regimen had significant side effects, while the low-dose regimen was well tolerated.
Easton's work on BRCA1 and BRCA2 gene mutations has significantly impacted breast cancer research. He established the Breast Cancer Linage Consortium, providing estimates of breast and ovarian cancer risk in BRCA1 mutation carriers.
A new technique for imaging the breast, positron emission mammography (PEM), has been found to be effective in detecting breast cancer without being affected by breast density or a woman's hormonal status. PEM has a higher sensitivity rate than standard mammography and breast MRI, with fewer false-positive results.
A new study presents a promising alternative to traditional treatments for women with breast implants who develop early-stage cancer. Brachytherapy, a targeted radiation treatment, offers better cosmetic outcomes and avoids the risk of implant hardening compared to whole-breast radiation therapy.
A program called Project Early Awareness teaches high school girls about breast health and self-exams, resulting in a 39% increase in comfort with performing a self-exam and a 69% increase in correct answers to breast cancer questions. The goal is for breast self-exams to become routine among young women.
Researchers aim to identify undiscovered genes involved in early breast cancer stages by studying genetic information from thousands of breast samples. The technique could help monitor women at higher risk due to inherited gene defects, reducing mortality from breast cancer.
A randomized trial of over 36,000 postmenopausal women found no association between calcium and vitamin D supplementation and reduced breast cancer risk. The findings challenge previous observational studies suggesting a potential link between vitamin D levels and breast cancer incidence.
A new study by the Mayo Clinic found that the Gail model, a widely used statistical tool for predicting breast cancer risk, was not reliable for women with atypical hyperplasia. The study tested the model in 331 women with atypia and found it predicted significantly fewer invasive breast cancers than were actually observed.
A study examining caffeine's association with breast cancer risk found that high caffeine intake may increase the risk of hormone-receptor negative and large breast tumors. The study also found a positive association between caffeine consumption and benign breast disease, but not overall breast cancer risk.
The Notch pathway plays a crucial role in regulating breast stem cell fate, controlling both stem cell number and the production of luminal cells. Errant activation of Notch leads to uncontrolled growth of luminal precursors, resulting in breast tumour formation.
Researchers at University of Missouri are studying the interactions between black cohosh and tamoxifen in a unique rat model to understand its safety and effectiveness. The goal is to provide reliable information on how women can use herbal supplements to enhance their breast cancer treatment and improve quality of life.
The new guidelines provide a tiered system of resource allocation to implement early detection, diagnosis, and treatment programs. The initiative aims to improve breast health outcomes in low- and middle-income countries, where cancer mortality rates are highest.
A study found that birth weight is associated with an increased risk of breast cancer later in life, particularly among women living in developed countries. The analysis of over 600,000 women revealed a 7% increase in risk for every 0.5 kg increment in birth weight.
A new study published in PLOS Medicine found that birth size is a significant marker of susceptibility to breast cancer later in life. The research analyzed data from over 600,000 women and discovered that a 0.5 kg increase in birth weight was associated with a 7% higher risk of breast cancer. Birth length and head circumference were a...
The breast cancer incidence in China is expected to increase due to lifestyle changes and adoption of Western lifestyles. Researchers predict a total of 2.5 million cases by 2012, with modifications to lifestyle and reproductive risk factors potentially preventing 270,000 cases.
A randomized study found that accelerated hypofractionated whole breast irradiation is as effective as standard five-week treatment in reducing local recurrence and side effects. The new therapy reduces the radiation time to three weeks, resulting in a cost savings of two-thirds compared to traditional treatment.
A new type of accelerated partial breast irradiation (APBI) called balloon brachytherapy is as effective in keeping breast cancer from coming back as standard external beam radiation. This shorter treatment option makes radiation therapy more convenient for patients, potentially increasing the rate of breast conservation.
A study found that reproductive and hormonal factors influence the risk of developing different subtypes of breast cancer. Breastfeeding for 6 months or longer was associated with a lower risk of luminal and triple-negative cancers, while late age at menopause and estrogen therapy were linked to increased risks.
Research finds that dense breast tissue promotes aggressive cancer cells, as breast cancer cells in denser surroundings step up their invasive activities. The study suggests a cellular mechanism linking human breast tissue density and tumor aggressiveness.
A recent study published in BMC Cancer reveals that a family history of breast cancer does not significantly increase the likelihood of developing the disease at an early age. The research suggests that applying strict screening criteria can help reduce unnecessary testing and alleviate psychological harm.
A new study from the University of Michigan Comprehensive Cancer Center found that HER2-positive breast cancers have four to five times more cancer stem cells than HER2-negative cancers. The drug Herceptin was shown to reduce cancer stem cell numbers by 80 percent, targeting and destroying these cells.
A U-M study found that breast asymmetry after cancer treatment significantly impacts a woman's quality of life, increasing the likelihood of depression, fear, and feelings of being less healthy. Women who experienced significant breast asymmetry were twice as likely to fear their cancer recurring than those with little to no asymmetry.
A recent ASPS study found that women who have breast reconstruction after an elective mastectomy are satisfied with their decision and have low complication rates. The study revealed a 98% satisfaction rate among patients who had bilateral prophylactic mastectomy, with 100% willing to undergo the procedure again.
Scientists at Thomas Jefferson University have discovered a key mechanism of breast cancer metastasis, where a gene dubbed 'Dachshund' (DACH1) regulates the production of IL-8, a common inflammatory protein. Blocking this protein with an antibody completely halted breast cancer spread in mice.
A new analysis of raloxifene, a medication approved for osteoporosis prevention and treatment, found it reduces the risk of invasive, estrogen-receptor positive breast cancer in postmenopausal women by at least 50% for up to 8 years. The drug is also effective in reducing the risk of spine fractures.
A randomized controlled trial found that raloxifene reduced the risk of invasive ER-positive breast cancer by 44% in postmenopausal women. The drug did not affect non-invasive cancers or those with osteoporosis without high breast cancer risk.
A new study from the University of Melbourne found that Kylie Minogue's breast cancer diagnosis led to a significant increase in breast imaging and biopsies among low-risk women, particularly those aged 25-34. Despite the surge in screening activity, the rates of breast cancer detection did not change significantly.
Women with a sister diagnosed with breast cancer face an increased risk of developing the disease throughout their lives. Regular exercise during adolescence and young adulthood is associated with a lower risk of premenopausal breast cancer. Meanwhile, disparities in rectal cancer outcomes persist despite access to oncologists, highlig...
A multicenter trial found that breast ultrasound combined with mammography detected more cancers than mammography alone in high-risk women. The study used over 2,800 participants, including 40 diagnosed with breast cancer, and showed that breast ultrasound is a cost-effective and non-invasive screening option.
The Breast Cancer Campaign emphasizes the need for improved quality of life and treatment options for survivors, citing advances in diagnosis and care. Despite increased survival rates, many survivors experience debilitating side effects such as fatigue and body image issues, affecting their psychological well-being.
A study of nearly 65,000 women found that physical activity significantly reduces the risk of premenopausal breast cancer. Women who exercised regularly had a 23% lower risk of developing breast cancer before menopause.
A review of 62 studies found that physical activity significantly reduces breast cancer risk in lean women, particularly those who engage in moderate and vigorous exercise after menopause. Obesity and family history of breast cancer counteract these benefits.
Preliminary research suggests that high-risk women with breast cancer who don't have a BRCA1/2 mutation may be at a higher risk of developing a second breast cancer. The study supports the use of prophylactic mastectomy as an option for these women, but raises questions about the role of sentinel node biopsy.
A recent study led by Northwestern Memorial physician Virginia Kaklamani suggests that variations of the adiponectin gene may increase a woman's risk of developing breast cancer. This discovery could lead to the development of a genetic testing model to predict breast cancer risk more accurately.
Researchers found that daily aspirin use was associated with a small reduction in the risk of ER+ breast cancer, but not total breast cancer risk. Aspirin's irreversible effects on cyclooxygenase enzymes may disrupt breast cancer development by reducing estrogen production.
Advances in breast reconstruction techniques, such as nipple-sparing mastectomy, DIEP flaps, and acellular dermis graft slings, are addressing the cosmetic issues left by lumpectomy. These innovative methods aim to create more natural-looking breasts with improved symmetry and aesthetics for breast cancer patients.
A study of 250 BRCA carriers found that prophylactic mastectomy significantly reduces the risk of developing breast cancer, with only one case detected. The cost of ongoing surveillance is high and can be stressful for patients, while intensive screening may not always detect cancer at an early stage.
A randomized controlled trial found that conjugated equine estrogen increased the risk of benign proliferative breast disease by more than two-fold. Women taking estrogen supplements had 155 cases of benign disease compared to 77 in the placebo group.
A comprehensive review of breast cancer research identifies key gaps in treatment and patient care, calling for increased attention on prevention, detection, and spread. The charity Breast Cancer Campaign is already funding innovative projects to fill these gaps and improve survival rates.
A new study has found that hormone replacement therapy (HRT) increases the risk of breast cancer recurrence in women who have survived breast cancer. The HABITS trial, which followed over 200 breast cancer survivors for four years, found that HRT significantly increased the risk of disease recurrence.
Researchers at UCSF have developed a new model for estimating breast cancer risk, incorporating breast density and ethnicity, which is well-calibrated and reasonably accurate across risk factor subgroups. The model may one day be used to calculate a woman's risk for breast cancer during mammograms.